| ID | Sequence | Length | GC content |
|---|---|---|---|
| AAUAGAGACAGGCAGACGGGCGAGCAGGAGAGCCAGCUGCCGCUGCUGG… | 6758 nt | 0.5361 | |
| AAUAGAGACAGGCAGACGGGCGAGCAGGAGAGCCAGCUGCCGCUGCUGG… | 6731 nt | 0.5362 | |
| AAUAGAGACAGGCAGACGGGCGAGCAGGAGAGCCAGCUGCCGCUGCUGG… | 16188 nt | 0.4691 | |
| GCAGGCAGGCAUUUGCUUAGAGCAGGCUGUGUGCGAGCCCAGCGUCAAG… | 6511 nt | 0.5231 | |
| AGUGGCUCCCAGUAAGUCAGAGCUGCGGCCGCGGUGCGGGGAGAGCACA… | 10889 nt | 0.4277 |
Huntington's disease (HD), a neurodegenerative disorder characterized by loss of striatal neurons, is caused by an expansion of a polyglutamine tract in the HD protein huntingtin. This gene encodes a protein that interacts with the huntingtin-associated protein 1, which is a huntingtin binding protein that may function in vesicle trafficking. [provided by RefSeq, Apr 2016]
A study in mice demonstrated that methamphetamine treatment reduced hnRNP H1 binding to intron 1 of the Kalrn mRNA, which codes for the KALIRIN protein linked to cocaine outcomes and synaptic plasticity [Ruan et al. DOI:10.1016/J.Pnpbp.2025.111598]. A study in mice demonstrated that active MDMA self-administration induces specific transcriptional changes in the brain related to reinforced learning, including the upregulation of the KALRN in the dorsal raphe nucleus compared to yoked controls, as validated by qRT-PCR [Fernandez-Castillo et al. DOI:10.1111/J.1601-183X.2011.00735.X].